Study; Hydroxychloroquine: Trump's Covid-19 'cure' increases deaths
- Thread starter moon
- Start date
Guno צְבִי
We fight, We win
Trumps cavalcade of imbeciles will now groan
Are these the same phony doctors who appear on Fox News???????????????????
anonymoose
Classical Liberal
One of my long time friends is an ER doc that sees covid19 patients.
He takes Hydroxychloroquine, zinc and doxycycline as a prophylactic measure.
Are you dumb enough to think a questionable incident has the same weight as a test involving 96,000 patients? You should be ashamed to counter with that.
I would not use chloroquine
smart.
the risk for non-comorbidity is very low, and even for those with cardiac issues as a prophylaxis is low.
India and Turkey are giving the hydroxychloroquine as well - add in the zinc for sure
jimmymccready
Verified User
Sure he does.
For the last year I've been taking Quercetin (which is also a zinc ionophore like HCQ). It's an inexpensive
OTC supplement, along with C, D3 and zinc in specific dosages. In short, these supps strengthen the immune
system against viruses. HAH!!! Who knew my combo would come in so handy within a few months!
Last edited:
THERE ARE DOZENS OF OTHER STUDIES THAT SHOW THE OPPOSITE....
Me neither. I think this was from the time they were all starting to get the correct semantics together and of course clarified it as HYDROXYchloroquine at some point.
He does call it HYDROXYchloroquine, though.
Tranquillus in Exile
New member
If there are dozens of other studies that show the opposite, why have none been cited here? All we've seen are a handful of 'doctors' who say "I prescribe it, it's great."
Oh yes, and it's used in Turkey and India.
That isn't a STUDY.
signalmankenneth
Verified User
A woman who has lupus took hydroxychloroquine for 19 years. She still got COVID-19
OCONOMOWOC, Wis. —
A Wisconsin woman who has had lupus for most of her life said she takes hydroxychloroquine and still caught COVID-19.
Kim, who only wants her first name used, said she has taken the anti-malarial drug for 19 years to help treat the pain caused by her lupus.
Kim said when the pandemic began, she only left her home to go to the grocery store. She said by mid-April though, she started feeling coronavirus symptoms.
"Weak all over. Coughing, fever. The fever was very high," Kim said. "It just went downhill from there. I couldn't breathe no more."
Kim said her primary care doctor prescribed antibiotics, but her condition worsened. She said when she went to an urgent care center days later, nurses said her oxygen saturation levels were at 78%, when they need to be at 95% or higher.
Kim said after arriving at a hospital, she tested positive for COVID-19.
https://www.kcci.com/article/a-woma...-for-19-years-she-still-got-covid-19/32611963
OCONOMOWOC, Wis. —
A Wisconsin woman who has had lupus for most of her life said she takes hydroxychloroquine and still caught COVID-19.
Kim, who only wants her first name used, said she has taken the anti-malarial drug for 19 years to help treat the pain caused by her lupus.
Kim said when the pandemic began, she only left her home to go to the grocery store. She said by mid-April though, she started feeling coronavirus symptoms.
"Weak all over. Coughing, fever. The fever was very high," Kim said. "It just went downhill from there. I couldn't breathe no more."
Kim said her primary care doctor prescribed antibiotics, but her condition worsened. She said when she went to an urgent care center days later, nurses said her oxygen saturation levels were at 78%, when they need to be at 95% or higher.
Kim said after arriving at a hospital, she tested positive for COVID-19.
https://www.kcci.com/article/a-woma...-for-19-years-she-still-got-covid-19/32611963
moon
Satire for Sanity
Crockmeister has no reason to appeal to- but your effort isn't entirely wasted.
OCONOMOWOC, Wis. —
A Wisconsin woman who has had lupus for most of her life said she takes hydroxychloroquine and still caught COVID-19.
Kim, who only wants her first name used, said she has taken the anti-malarial drug for 19 years to help treat the pain caused by her lupus.
Kim said when the pandemic began, she only left her home to go to the grocery store. She said by mid-April though, she started feeling coronavirus symptoms.
"Weak all over. Coughing, fever. The fever was very high," Kim said. "It just went downhill from there. I couldn't breathe no more."
Kim said her primary care doctor prescribed antibiotics, but her condition worsened. She said when she went to an urgent care center days later, nurses said her oxygen saturation levels were at 78%, when they need to be at 95% or higher.
Kim said after arriving at a hospital, she tested positive for COVID-19.
https://www.kcci.com/article/a-woma...-for-19-years-she-still-got-covid-19/32611963
Yup. It just makes the trip a little easier. Get over it.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
3/20/20
Abstract
Background
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads.
Patients and methods
French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting. Depending on their clinical presentation, azithromycin was added to the treatment. Untreated patients from another center and cases refusing the protocol were included as negative controls. Presence and absence of virus at Day6-post inclusion was considered the end point.
Results
Six patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.
Twenty cases were treated in this study and showed a significant reduction of the viral carriage at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature. Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.
Conclusion
Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.
Key words: 2019-nCoV, SARS-CoV-2, COVID-19, hydroxychloroquine, azithomycin, clinical trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102549/
3/20/20
Abstract
Background
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads.
Patients and methods
French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting. Depending on their clinical presentation, azithromycin was added to the treatment. Untreated patients from another center and cases refusing the protocol were included as negative controls. Presence and absence of virus at Day6-post inclusion was considered the end point.
Results
Six patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.
Twenty cases were treated in this study and showed a significant reduction of the viral carriage at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature. Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.
Conclusion
Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.
Key words: 2019-nCoV, SARS-CoV-2, COVID-19, hydroxychloroquine, azithomycin, clinical trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102549/
